Sales Milestone Events definition

Sales Milestone Events has the meaning set forth in Section 10.2.2 (Sales Milestone Events and Payments).
Sample 1Sample 2Sample 3
Sales Milestone Events means the eighth and ninth milestone events specified in Section 5.2.
Sample 1Sample 2Sample 3
Sales Milestone Events has the meaning set forth in Section 7.2.
Sample 1Sample 2

Examples of Sales Milestone Events in a sentence

  • It claims to have reduced the drag coefficient to 0.06, which results in 20% less fuel consumption.FIGURE 1 THE KINGFISHER BIRD AND THE BULLET TRAIN the kingfisher (Figure 1).

  • To complete this work, GAO reviewed agency policies and reports, interviewed officials, and analyzed agency data.

  • If in any calendar year, aggregate Net Sales equal an amount such that two or more previously unachieved Net Sales Milestone Events were achieved, Buyer is [***].

  • Regarding their religion 43 (54%) was Orthodox followed by Protestant28 (35%).

  • All Ionis Royalty Reports and reports identifying Ionis Product Development Milestone Events, Ionis Product Regulatory Milestone Events, and Ionis Product Sales Milestone Events will be considered Confidential Information of Ionis.

  • Buyer and Seller acknowledge and agree that nothing in this Agreement shall be construed as representing an estimate or projection of anticipated regulatory approval or sales of a Product, and that the Sales Milestone Events set forth above or elsewhere in this Agreement or that have otherwise been discussed by the Parties are merely intended to define the Sales Milestone Payments to Seller in the event such Sales Milestone Events are achieved.

  • For clarity, the Sales Milestone Payments are additive, such that if more than one Sales Milestone Events are achieved in the same time period, then the Sales Milestone Payments for all such Sales Milestone Events shall be payable.

  • Lian will pay to Lyra each of the non-refundable, non-creditable, and not subject to set-off, Sales Milestone Payments set forth below in Table 6.1(c) (Sales Milestone Events) within [***] days of providing notice of each Sales Milestone Event (each, a “Sales Milestone Payment”).

  • No explanation was provided on failure by the Board to meet and approve licenses during the year.1.1 Failure to Comply with Public Finance Management Act 2012During the financial year, the County Executive did not prepare, publish and publicize quarterly cash flows reports that were supported by approved procurement plan as required by Section 43 (3),(4),(6) of the Public Finance Management Act 2012.

  • If more than one of the above Sales Milestone Events is achieved in the same year, JBI will pay all applicable milestone payments.


More Definitions of Sales Milestone Events

Sales Milestone Events means each of the First Sales Milestone Event, the Second Sales Milestone Event, the Third Sales Milestone Event and the Fourth Sales Milestone Event.
Sample 1Sample 2Sample 3
Sales Milestone Events means any of the Ophthalmic Sales Milestone Events, Ex-Vivo [***] Sales Milestone Events, or In-Vivo [***] Sales Milestone Events.
Sample 1Sample 2Sample 3
Sales Milestone Events means, collectively, Milestone Event 2, Milestone Event 3, Milestone Event 4, Milestone Event 5, Milestone Event 6, and Milestone Event 7.
Sample 1Sample 2
Sales Milestone Events and the sales milestone payments set forth in Table 9.2.2, the “Sales Milestone Payments”).
Sample 1Sample 2
Sales Milestone Events has the meaning set forth in Section 4.3.
Sample 1
Sales Milestone Events shall have the meaning set forth in Section 6.5.1.
Sample 1

Related to Sales Milestone Events

  • Milestone Events has the meaning set forth in Section 7.2.

  • Milestone Event has the meaning set forth in Section 8.2.1.

  • Development Milestone Event has the meaning set forth in Section 7.2.1.

  • Sales Milestone Payment shall have the meaning set forth in Section 8.4.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Development Milestone is defined in Section 5.3.

  • Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.

  • Milestone means an event or task described in the Implementation Plan which must be completed by the corresponding date set out in such plan;

  • Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.

  • Milestone Date means the date set against the relevant Milestone in the Implementation Plan;

  • Project Milestone means the project milestone set forth in Schedule-J;

  • Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.

  • Milestone Payment has the meaning set forth in Section 4.2.

  • Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.

  • Project Milestones means the project milestones set forth in Schedule-G;

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Milestones means control points in the project that help to chart progress. Milestones may correspond to the completion of a key deliverable, allowing the next phase of the work to begin. They may also be needed at intermediary points so that, if problems have arisen, corrective measures can be taken. A milestone may be a critical decision point in the project where, for example, the consortium must decide which of several technologies to adopt for further development.

  • Milestone Payments means payments made in connection with any Permitted Acquisition or other acquisition (including any license or the acquisition of any license) of any rights in respect of any drug or other pharmaceutical product (and any related property or assets) to sellers (or licensors) of the assets or Equity Interests acquired (or licensed) therein based on the achievement of specified revenue, profit or other performance targets (financial or otherwise).

  • Milestone Schedule means Seller’s milestone schedule, the form of which is attached to this Agreement as Exhibit Q.

  • Milestone Notice has the meaning set forth in Section 2.4(a).

  • Milestone Failure means a failure by the Grant Recipient fully to achieve any Milestone by the relevant Milestone Date;

  • EBITDA Target means the Company's projected earnings before interest, taxes, one-time transition expenses, non-cash compensation expense charges, depreciation and amortization, as contained in the Company's budget for the Applicable Period and which is approved by the Board (without reference to any adjustments or revision, upwards or downwards, to such projected earnings which are subsequently approved by the Board as part of any subsequent revision to such budget), and (ii) the term "Financial Results" shall mean the Company's EBITDA calculated by reference to the Company's financial statements for the Applicable Period as filed with the Securities and Exchange Commission (the "SEC").

  • Third Target Distribution means $0.5250 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.5250 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.

  • Second Target Distribution means $0.4375 per Unit per Quarter (or, with respect to the period commencing on the Closing Date and ending on September 30, 2005, it means the product of $0.4375 multiplied by a fraction of which the numerator is equal to the number of days in such period and of which the denominator is 92), subject to adjustment in accordance with Section 6.6 and Section 6.9.

  • KPI Target means the acceptable performance level for a KPI as set out in each KPI;

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.